Large Dosage of Chishao in formulae for cholestatic hepatitis: A systematic review and meta-analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Ma, Xiao ^a,b   Wang, Ji ^c   He, Xuan ^c   Zhao, Yanling ^b   Wang, Jiabo ^b   Zhang, Ping ^b   Zhu, Yun ^b   Zhong, Lin ^a,b   Zheng, Quanfu ^a,b   Xiao, Xiaohe ^b  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING 302 HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALANINE AMINOTRANSFERASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHISHAO EXTRACT; DIAMMONIUM GLYCYRRHIZINATE; GLUCURONOLACTONE; GLYCYRRHIZIC ACID DERIVATIVE; PHYTOMENADIONE; PLACEBO; PLANT EXTRACT; PROSTAGLANDIN E1; S ADENOSYLMETHIONINE; SILYMARIN; SPARAGIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

CHOLESTATIC HEPATITIS; COCHRANE LIBRARY; DATA BASE; DIGESTIVE SYSTEM DISEASE; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; INFORMATION SYSTEM; MEDLINE; META ANALYSIS; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SYSTEMATIC REVIEW;

EID: 84903516556     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/328152     Document Type: Review

References (47)

1. Jin F., Cheng D., Tao J. Y., Zhang S., Pang R., Guo Y., Ye P., Dong J., Zhao L., Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis. BMC Gastroenterology 2013 13 1, article 79 2-s2.0-84876981277 10.1186/1471-230X-13-79
2. Zhao Y., Zhou G., Wang J., Jia L., Zhang P., Li R., Shan L., Liu B., Song X., Liu S., Xiao X., Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats. Food and Chemical Toxicology 2013 58 242 248 2-s2.0-84878159408 10.1016/j.fct.2013.04.030
3. Zhu C., Cao H., Zhou X., Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis. Evidence-Based Complementary and Alternative Medicine 2013 2013 8 842824 10.1155/2013/842824
4. Yang D., Gao G. J., Wei K., Wang X. J., Sun F. X., Clinical analysis of cholestatic hepatitis characteristic. Chinese Journal of Clinicians 2011 5 24 7423 7424
5. Yang D., Sun F. X., Gao G. J., Wei K., Wang X. J., Evaluation on herbal Yudan decoction on treatment of acute cholestatic hepatitis. Chinese Journal of Liver Diseases 2013 5 3 9 11
6. Zhang L., Wang G., Hou W., Li P., Dulin A., Bonkovsky H. L., Contemporary clinical research of traditional chinese medicines for chronic hepatitis B in china: an analytical review. Hepatology 2010 51 2 690 698 2-s2.0-75449093008 10.1002/hep.23384
7. Xia Y., Luo H., Liu J. P., Gluud C., Phyllanthus species for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews 2011 4 CD008960 2-s2.0-79955650806
8. Liu H. M., Wang X. B., Chang Y. J., Gu L. L., Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine 2012 10 11 1211 1228 2-s2.0-84871437402 10.3736/jcim20121104
9. Li S., Zhang B., Traditional Chinese medicine network pharmacology: theory, methodology and application. Chinese Journal of Natural Medicines 2013 11 2 110 120 2-s2.0-84879147636 10.1016/S1875-5364(13)60037-0
10. Li S., Zhang Z. Q., Wu L. J., Zhang X. G., Li Y. D., Wang Y. Y., Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Systems Biology 2007 1 1 51 60 2-s2.0-34249037449 10.1049/iet-syb:20060032 (Pubitemid 46779218)
11. Wang C. B., He J. P., Lei Z. Y., Chen J. M., Treating cholestatic hepatitis with large dosage of Chishao for cooling blood and promoting blood flow-13 cases report. Journal of Traditional Chinese Medicine 1983 6 30 32
12. He J. P., Wang C. B., Treatment of severe cholestatic hepatitis by integrative medicines. Chinese Journal of Integrative Medicine 1998 4 1 18 21
13. Wei S. S., Zhao Y. L., Jiang F. J., Investigation of high dosage of Paeoniae Radix Rubra against ANIT-induced acute cholestasis hepatitis in rats. Chinese Journal of Experimental Traditional Medical Formulae 2012 18 12 151 155
14. Tang X. Q., Xu W. Q., Cheng X. J., Yinchen Xiaodan method combined with western medicine in treatment of chronic hepatitis B with intrahepatic cholestasis randomized parallel controlled study. Journal of Practical Traditional Chinese Internal Medicine 2013 27 3 79 80
15. Chen Z. Q., Tu Y. Y., Clinical observation of 30 cases of cholestatic hepatitis treating with ancient Jiawei prescription. Inner Mongol Journal of Traditional Chinese Medicine 2013 12 18 19
16. Wu Q. B., control observation of Huoxue Qingdan decoction in treating chronic cholestatic hepatitis. Journal of Practical Traditional Chinese Internal Medicine 2012 26 8 49 51
17. Xu C. J., Guo W. S., Xie Y. F., Clinical observation of 30 cases of severe cholestatic hepatitis treating with combined tratitional Chinsese medicine and western medicine. Modern Journal of Integrated Traditional Chinese and Western Medicine 2011 20 20 2531 2532
18. Zhu X. J., Clinical observation of cholestatic hepatitis treated with large dose Chishao. Clinical Journal of Traditional Chinese Medicine 2010 22 2 144 145
19. He S. M., Huang B., Deng X., 32 Cases of severe cholestatic hepatitis treated with Chi Yin Tui Huang decoction combined with western medicine. Shaanxi Journal of Traditional Chinese Medicine 2008 29 5 564 566
20. Xie C. J., Ma W. B., Li R. C., Wang S. Y., 60 Cases of cholestatic hepatitis treated with Chishao Tuihuang decoction research. Capital Medicine 2008 6 49
21. Shu Z. E., Clinical Observation of Chronic Cholestatic Hepatitis Treated with Wen Li Huo Xue Decoction 2007 Hubei University of Chinese Medicine
22. Li Y. F., Clinical Observation of Chronic Viral Cholestatic Hepatitis After Treatment with Jian Pi Li Dan Decoction 2006 Hubei University of Chinese Medicine
23. He J. P., Wang C. B., Ding J. B., Comparison of Chidan Tuihuang granule and Galle-Donau in the treatment of acute and chronic viral cholestatic hepatitis. Chinese Journal of New Drugs 2003 12 3 209 212
24. He J. P., Wang C. B., Ding J. B., Open comparative study of Chidan Tuihuang granule in treating acute and chronic viral cholestatie hepatitis. Chinese Journal of Integrated Traditional and Wetern Medicine 2003 23 7 498 500
25. Chinese Medical Association, Viral hepatitis prevention and treatment programs. Infectious Disease Information 2000 13 4 141 150
26. Zheng X. Y., Guidance for Clinical Research on New Drugs of TCM 2002 China Medical Science Press
27. Poupon R., Chazouilleres O., Poupon R. E., Chronic cholestatic diseases. Journal of Hepatology 2000 32 1, supplement 129 140 2-s2.0-0034006662 (Pubitemid 30123630)
28. Kakizaki S., Takizawa D., Tojima H., Horiguchi N., Yamazaki Y., Mori M., Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease. Frontiers in Bioscience 2011 16 7 2988 3003 2-s2.0-79959548856 10.2741/3893
29. Anthérieu S., Azzi P. B., Dumont J., Abdel-Razzak Z., Guguen-Guillouzo C., Fromenty B., Robin M., Guillouzo A., Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology 2013 57 4 1518 1529 2-s2.0-84876132701 10.1002/hep.26160
30. Allen K., Jaeschke H., Copple B. L., Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. The American Journal of Pathology 2011 178 1 175 186 2-s2.0-78650793157 10.1016/j.ajpath.2010.11.026
31. Geier A., Wagner M., Dietrich C. G., Trauner M., Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochimica et Biophysica Acta-Molecular Cell Research 2007 1773 3 283 308 2-s2.0-33847011377 10.1016/j.bbamcr.2006.04.014 (Pubitemid 46275063)
32. Keppler D., Cholestasis and the role of basolateral efflux pumps. Zeitschrift für Gastroenterologie 2011 49 12 1553 1557 2-s2.0-82955184472 10.1055/s-0031-1281755
33. Buryova H., Chalupsky K., Zbodakova O., Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity. BMC Gastroenterology 2013 13 1, article 155 10.1186/1471-230X-13-155
34. Arenas F., Hervias I., Úriz M., Joplin R., Prieto J., Medina J. F., Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. Journal of Clinical Investigation 2008 118 2 695 709 2-s2.0-38849104576 10.1172/JCI33156 (Pubitemid 351206558)
35. Fang Z., Lu B., Liu M., Zhang M., Yi Z., Wen C., Shi T., Evaluating the pharmacological mechanism of Chinese medicine Si-Wu-Tang through multi-level data integration. PLoS ONE 2013 8 11 e72334 10.1371/journal.pone.0072334
36. Liu J., Pei M., Zheng C., Li Y., Wang Y., Lu A., Yang L., A systems-pharmacology analysis of herbal medicines used in health improvement treatment: predicting potential new drugs and targets. Evidence-Based Complementary and Alternative Medicine 2013 2013 17 938764 10.1155/2013/938764
37. Zhang A., Sun H., Qiu S., Wang X., Advancing drug discovery and development from active constituents of Yinchenhao Tang, a famous traditional Chinese medicine formula. Evidence-Based Complementary and Alternative Medicine 2013 2013 6 257909 10.1155/2013/257909
38. Wang Y. Z., Feng W. S., Shi R. B., Liu B., Jiang Y. Y., Monoterpenes of Paeonia lactiflora Pall. Chinese Pharmaceutical Journal 2008 43 9 669 671 2-s2.0-52749092470
39. Yang Y. Y., Zhou G., Ma X. K., Research progress of Paeonia lactiflora Pall. Herald of Medicine 2008 27 1 67 69
40. Jin S. N., Wen J. F., Wang T. T., Kang D. G., Lee H. S., Cho K. W., Vasodilatory effects of ethanol extract of Radix Paeoniae Rubra and its mechanism of action in the rat aorta. Journal of Ethnopharmacology 2012 142 1 188 193 2-s2.0-84861985249 10.1016/j.jep.2012.04.035
41. Lee B., Shin Y. W., Bae E. A., Han S., Kim J., Kang S., Kim D., Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol. Archives of Pharmacal Research 2008 31 4 445 450 2-s2.0-43049141859 10.1007/s12272-001-1177-6
42. He D. Y., Dai S. M., Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine. Frontiers in Pharmacology 2011 2, article 10 2-s2.0-82255180232 10.3389/fphar.2011.00010
43. Bourbonnais É., Raymond V., Éthier C., Nguyen B. N., Elleil M. S., Meloche S., Bilodeau M., Liver fibrosis protects mice from acute hepatocellular injury. Gastroenterology 2012 142 1 130.e4 139.e4 2-s2.0-83955162351 10.1053/j.gastro.2011.09.033
44. Wang J. B., Zhao H. P., Zhao Y. L., Jin C., Liu D., Kong W., Fang F., Zhang L., Wang H., Xiao X., Hepatotoxicity or hepatoprotection? pattern recognition for the paradoxical effect of the chinese herb Rheum palmatum L. in treating rat liver injury. PLoS ONE 2011 6 9 2-s2.0-80052432734 10.1371/journal.pone.0024498 e24498
45. Jiang F., Zhao Y., Wang J., Wei S., Wei Z., Li R., Zhu Y., Sun Z., Xiao X., Comparative pharmacokinetic study of paeoniflorin and albiflorin after oral administration of Radix Paeoniae Rubra in normal rats and the acute cholestasis hepatitis rats. Fitoterapia 2012 83 2 415 421 2-s2.0-84855987226 10.1016/j.fitote.2011.12.009
46. Liaw Y. F., Impact of therapy on the outcome of chronic hepatitis B. Liver International 2013 33 supplement 1 111 115 2-s2.0-84872040813 10.1111/liv.12057
47. Marincola F. M., Translational medicine: a two-way road. Journal of Translational Medicine 2003 1 1, article 1 2-s2.0-0742272223 10.1186/1479-5876-1-1 (Pubitemid 39130333)